Overview
Lupin Limited is a leading global pharmaceutical company, known for its innovation in creating high-quality, affordable medicines. Operating in over 100 countries, Lupin specializes in branded and generic formulations, biotechnology, and complex generics, with a strong focus on addressing critical health challenges and improving patient outcomes worldwide.
Velocitta India, partnered with Lupin Ltd on designing its integrated report themed “Empowering Health ,” aligning with Lupin’s mission to enhance global healthcare by engaging with all the stakeholders in the value chain.
Case Timeline
2023
Brand
Lupin Limited | Integrated Report Design
Background
Velocitta India delivered expert creative design support for Lupin’s Integrated Report under the theme ‘Empowering Health’. We developed a unified visual identity that aligns with Lupin’s dedication to health empowerment, sustainability objectives, and financial achievements. Our strategic approach was to illustrate Lupin’s commitment to creating long-term value for stakeholders through a seamless fusion of corporate data and engaging storytelling, effectively reflecting the company’s pivotal role in advancing global health.
Cohesive Visual Narrative
We created a seamless flow throughout the report, ensuring the design aligns with the core message and branding, guiding the reader through each section effortlessly.
Clean Layout
We maintained a clean layout with thoughtful use of white space to ensure key information is clear and accessible.
Through innovative design elements and clear communication, the report effectively conveyed Lupin’s business philosophy, positioning it as a forward-thinking leader in the pharmaceutical industry.
Data Visualization
The design focuses on turning complex data into engaging visuals like infographics and charts to simplify understanding.
Sustainability & Innovation Highlighting
Visual elements are incorporated to emphasize themes like sustainability and innovation, making the company’s commitments resonate clearly throughout the report.
